Logo image of VEC

Vectrus Inc (VEC) Stock Fundamental Analysis

NYSE:VEC - New York Stock Exchange, Inc. - US92242T1016 - Common Stock

32.84  +0.21 (+0.64%)

Fundamental Rating

2

VEC gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 64 industry peers in the Aerospace & Defense industry. VEC may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, VEC is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year VEC was profitable.
VEC Yearly Net Income VS EBIT VS OCF VS FCFVEC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M

1.2 Ratios

Industry RankSector Rank
ROA 4.06%
ROE 10.31%
ROIC 8.47%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VEC Yearly ROA, ROE, ROICVEC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 10 20 30

1.3 Margins

Industry RankSector Rank
OM 2.81%
PM (TTM) 2.02%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VEC Yearly Profit, Operating, Gross MarginsVEC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2 4 6 8

More info and screens

3

2. Health

2.1 Basic Checks

VEC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, VEC has more shares outstanding
The debt/assets ratio for VEC has been reduced compared to a year ago.
VEC Yearly Shares OutstandingVEC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2M 4M 6M 8M 10M
VEC Yearly Total Debt VS Total AssetsVEC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M

2.2 Solvency

VEC has an Altman-Z score of 3.15. This indicates that VEC is financially healthy and has little risk of bankruptcy at the moment.
VEC has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 3.15
ROIC/WACC1.01
WACC8.36%
VEC Yearly LT Debt VS Equity VS FCFVEC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.22 indicates that VEC should not have too much problems paying its short term obligations.
VEC has a Quick Ratio of 1.22. This is a normal value and indicates that VEC is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.22
VEC Yearly Current Assets VS Current LiabilitesVEC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M

More info and screens

5

3. Growth

3.1 Past

VEC shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.38%.
Measured over the past years, VEC shows a quite strong growth in Earnings Per Share. The EPS has been growing by 12.37% on average per year.
VEC shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.22%.
VEC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.42% yearly.
EPS 1Y (TTM)-9.38%
EPS 3Y9.59%
EPS 5Y12.37%
EPS Q2Q%-76.47%
Revenue 1Y (TTM)22.22%
Revenue growth 3Y11.72%
Revenue growth 5Y8.42%
Sales Q2Q%5.18%

3.2 Future

The Earnings Per Share is expected to grow by 18.65% on average over the next years. This is quite good.
The Revenue is expected to grow by 3.24% on average over the next years.
EPS Next Y-9.18%
EPS Next 2Y33.48%
EPS Next 3Y9.35%
EPS Next 5Y18.65%
Revenue Next Year4.03%
Revenue Next 2Y9.35%
Revenue Next 3Y3.33%
Revenue Next 5Y3.24%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
VEC Yearly Revenue VS EstimatesVEC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
VEC Yearly EPS VS EstimatesVEC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6 8

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

VEC is valuated reasonably with a Price/Earnings ratio of 10.63.
The average S&P500 Price/Earnings ratio is at 26.68. VEC is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 4.76, which indicates a rather cheap valuation of VEC.
VEC is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.50, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.63
Fwd PE 4.76
VEC Price Earnings VS Forward Price EarningsVEC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.19
VEC Per share dataVEC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.86
EPS Next 2Y33.48%
EPS Next 3Y9.35%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for VEC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Vectrus Inc

NYSE:VEC (7/7/2022, 9:09:08 PM)

32.84

+0.21 (+0.64%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)05-10 2022-05-10/amc
Earnings (Next)N/A N/A
Inst Owners278.64%
Inst Owner Change4.07%
Ins Owners2.28%
Ins Owner Change0%
Market Cap387.51M
Analysts77.14
Price Target54.57 (66.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 10.63
Fwd PE 4.76
P/S 0.21
P/FCF N/A
P/OCF N/A
P/B 1.09
P/tB N/A
EV/EBITDA 7.19
EPS(TTM)3.09
EY9.41%
EPS(NY)6.89
Fwd EY21%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS153.06
BVpS30.02
TBVpSN/A
PEG (NY)N/A
PEG (5Y)0.86
Profitability
Industry RankSector Rank
ROA 4.06%
ROE 10.31%
ROCE N/A
ROIC 8.47%
ROICexc N/A
ROICexgc 29.69%
OM 2.81%
PM (TTM) 2.02%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover2.01
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 1.22
Altman-Z 3.15
F-Score5
WACC8.36%
ROIC/WACC1.01
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.38%
EPS 3Y9.59%
EPS 5Y12.37%
EPS Q2Q%-76.47%
EPS Next Y-9.18%
EPS Next 2Y33.48%
EPS Next 3Y9.35%
EPS Next 5Y18.65%
Revenue 1Y (TTM)22.22%
Revenue growth 3Y11.72%
Revenue growth 5Y8.42%
Sales Q2Q%5.18%
Revenue Next Year4.03%
Revenue Next 2Y9.35%
Revenue Next 3Y3.33%
Revenue Next 5Y3.24%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A